Fmoc-O-trityl-D-serine is a protected amino acid derivative in which the serine side chain hydroxyl is O-tritylated and the α-amino functionality is protected as an Fmoc carbamate, yielding a stereodefined D-serine scaffold. The molecule contains both an Fmoc-protected amino group and a carboxyl group, while the trityl ether masks the primary alcohol to reduce side reactions during peptide coupling and to control chemoselectivity. In peptide synthesis workflows, this protected analogue functions as a stepwise building block for introducing a serine residue bearing an orthogonally masked side-chain hydroxyl, supporting the preparation of peptide and amino-acid derivative targets for structure-activity studies and chemical biology labeling.
CAT No: CP01824
Fmoc-O-trityl-D-serine is a chiral, protected serine derivative in which the amino group is masked as an Fmoc carbamate and the side-chain hydroxyl is protected as an O-trityl ether. The D-configuration at the serine alpha-carbon provides defined stereochemical control for peptide coupling and for stereospecific incorporation into peptide sequences or peptidomimetic scaffolds. The combination of a base-labile Fmoc group and a bulky acid-stable trityl ether creates a selective deprotection profile that supports orthogonal protection strategies during protected amino acid synthesis. The molecule presents an activated carbamate for standard peptide chemistry while retaining an ether-protected hydroxyl that can be unmasked for downstream functionalization after assembly or during fragment elaboration.
1. Protected Peptide Synthesis
Fmoc-O-trityl-D-serine is used in automated and manual peptide synthesis where the Fmoc-protected amine enables sequential N-terminal deprotection and coupling to carboxylic acid partners. The O-trityl side-chain protection stabilizes the serine hydroxyl against undesired acylation or side reactions during peptide bond formation, while the D-stereocenter maintains stereochemical fidelity for D-serine-containing peptides. Orthogonal deprotection of the Fmoc group supports controlled chain elongation, followed by later unmasking of the side-chain hydroxyl for serine-specific chemistry. The resulting peptide building block supports generation of protected peptide intermediates and structure-defined peptide analogs used in biochemical research and peptide materials development.
2. Side-Chain Functionalization
Fmoc-O-trityl-D-serine supports side-chain modification workflows in chemical biology and synthetic organic chemistry by providing a protected serine hydroxyl that can be revealed when trityl removal is triggered under appropriate conditions. The trityl ether protects the hydroxyl during coupling steps, minimizing competing reactions such as O-acylation or crosslinking, while the D-configuration can influence binding modes in stereochemically defined ligands. Unmasked serine alcohol functionality can then be converted into phosphorylated, glycosylated, sulfonylated, or ether-linked derivatives depending on the chosen transformation strategy. Downstream use includes preparing functionalized peptide fragments, immobilizable linkers for assay surfaces, and stereodefined building blocks for peptidomimetic construction.
3. Bioconjugation Linkers
Fmoc-O-trityl-D-serine is applicable to bioconjugation chemistry where D-serine-containing peptides or peptide fragments serve as controlled spacers and recognition elements in conjugate design. The Fmoc-protected amine and trityl-protected hydroxyl facilitate stepwise synthesis of conjugatable peptide segments that can be deprotected to introduce reactive handles at defined positions. The side-chain hydroxyl can be transformed into coupling-ready groups, enabling attachment to biomolecules, polymers, or nanoparticles through hydroxyl-derived chemistries. This makes the compound relevant to producing labeled peptide reagents, affinity probes, and modular conjugation intermediates for analytical research and specialty chemical production.
4. Chiral Amino Acid Intermediate
Fmoc-O-trityl-D-serine functions as a chiral amino acid intermediate for stereoselective synthesis of D-serine derivatives and for manufacturing routes that require orthogonally protected functional groups. The presence of both an Fmoc carbamate and an O-trityl ether provides a protected framework that can be carried through multi-step sequences, allowing selective unveiling of the amine or side-chain alcohol at different stages. The stereochemical integrity of the D-center supports downstream formation of D-serine-containing intermediates used in fine chemical synthesis and peptide-based scaffold development. The protected architecture also aligns with process chemistry needs for isolable intermediates that can be converted into broader classes of protected amino acid derivatives and peptide building blocks.
5. Pharmaceutical Intermediate Preparation
Fmoc-O-trityl-D-serine is suitable for pharmaceutical intermediate preparation and process chemistry contexts where controlled protection of both the amino functionality and the serine hydroxyl is required for scalable peptide or peptidomimetic synthesis. The Fmoc group supports standardized N-protection logic compatible with common peptide coupling workflows, while the bulky trityl ether helps suppress side reactions that could complicate purification of partially assembled sequences. The D-serine stereochemistry can be incorporated into peptide-like intermediates intended for SAR studies and molecular design, enabling generation of stereodefined analog libraries. Downstream utility includes producing protected peptide fragments and functionalized amino acid derivatives that serve as inputs to further derivatization and industrial fine chemical manufacturing steps.
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More